 | Sulfaphenazole | IC50 | 318.0 [1] |
| Sulfaphenazole | Ki | 200.0 [1], 500.0 [2] |
 | Fluconazole | IC50 | 9210.0 [1], 13000.0 [2], 29000.0 [3], 34000.0 [4] |
 | Voriconazole | IC50 | 3620.0 [1], 8400.0 [2], 14000.0 [3] |
| Voriconazole | Ki | 2800.0 [1] |
 | Unii-G6gso9sdnj | IC50 | 200.0 [1], 1000.0 [2] |
 | alpha-Naphthoflavone | IC50 | 10000.0 [1], 20000.0 [2] |
 | Benzbromarone | IC50 | 50000.0 [1] |
| Benzbromarone | Ki | 19.0 [1] |
 | MK-7246 | IC50 | 5000.0 [1], 9000.0 [2], 9400.0 [3] |
 | Ketoconazole | IC50 | 8940.0 [1], 40000.0 [2] |
 | Nicardipine | IC50 | 378.0 [1], 660.0 [2] |
| Nicardipine | Ki | 280.0 [1] |
 | Auglurant | IC50 | 12100.0 [1], 29900.0 [2] |
 | 2-{3-[1-(4-Hydroxyphenyl)-5-methyl-1H-pyrazol-4-yl]propanamido}benzoic acid | IC50 | 15000.0 [1], 22000.0 [2] |
 | N-(2,4-Dichlorobenzyl)-4-(pyrimidin-2-yloxy)piperidine-1-carboxamide | IC50 | 20000.0 [1], 25500.0 [2] |
 | 4-[4-[2-[(3S)-3-Hydroxy-1-azabicyclo[2.2.2]octan-3-yl]ethynyl]phenoxy]-N-(pyrimidin-4-ylmethyl)benzamide | IC50 | 10000.0 [1], 50118.72 [2] |
 | (6S)-3-[(1S)-1-[4-(2,4-Difluorophenyl)phenyl]ethyl]-6-(4-fluorophenyl)-6-(2-hydroxyethyl)-1,3-oxazinan-2-one | IC50 | 4100.0 [1], 4900.0 [2] |
 | [4-[(3R)-4-[5-(Hydroxymethyl)-4-(trifluoromethyl)pyrimidin-2-yl]-3-propan-2-ylpiperazin-1-yl]-2-methylsulfonylphenyl]methanol | IC50 | 608.0 [1], 610.0 [2], 2200.0 [3] |
 | (6S)-6-(2-Hydroxy-2-methylpropyl)-3-[(1S)-1-[4-(1-methyl-6-oxopyridin-3-yl)phenyl]ethyl]-6-phenyl-1,3-oxazinan-2-one | IC50 | 24800.0 [1], 43000.0 [2] |
 | (6S)-6-(2-Hydroxy-2-methylpropyl)-3-[(1S)-1-[4-(1-methyl-2-oxopyridin-4-yl)phenyl]ethyl]-6-phenyl-1,3-oxazinan-2-one | IC50 | 30000.0 [1], 50000.0 [2] |
 | 2,2,2-Trifluoro-1-(5-(4-(3-methoxyphenyl)piperazine-1-carbonyl)thiophen-2-yl)ethanone | IC50 | 5000.0 [1], 8000.0 [2] |
 | N-(1-(Naphthalen-1-yl)ethyl)-5-(2,2,2-trifluoroacetyl)thiophene-2-carboxamide | IC50 | 1400.0 [1], 11000.0 [2], 17000.0 [3] |
 | N-(1-(Pyridin-4-yl)ethyl)-5-(2,2,2-trifluoroacetyl)thiophene-2-carboxamide | IC50 | 3000.0 [1], 10000.0 [2], 13000.0 [3] |
 | 2,2,2-Trifluoro-1-[5-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)piperidine-1-carbonyl]thiophen-2-yl]ethanone | IC50 | 5000.0 [1], 8000.0 [2] |
 | Verapamil | IC50 | 30000.0 [1], 50000.0 [2] |
 | Phenytoin | Ki | 6000.0 [1], 10000.0 [2] |
 | Quercetin | IC50 | 10200.0 [1] |
| Quercetin | Ki | 27000.0 [1] |
 | Haloperidol | IC50 | 30000.0 [1], 50000.0 [2] |
 | Linezolid | IC50 | 20000.0 [1] |
 | Sertraline | IC50 | 10000.0 [1], 50000.0 [2] |
 | Indinavir | IC50 | 30000.0 [1] |
 | Duloxetine | IC50 | 29000.0 [1], 29100.0 [2] |
 | Pentamidine | IC50 | 100000.0 [1] |
 | Dicumarol | Ki | 600.0 [1], 1900.0 [2] |
 | Posaconazole | IC50 | 7200.0 [1], 109000.0 [2] |
 | 4-[(7-Chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol;hydrochloride | IC50 | 62000.0 [1] |
 | Bepridil | IC50 | 4310.0 [1], 30000.0 [2] |
 | Gingerol | IC50 | 12100.0 [1], 27900.0 [2] |
 | Dolutegravir | IC50 | 100000.0 [1] |
 | Daclatasvir | IC50 | 59500.0 [1] |
 | Saxagliptin | IC50 | 50000.0 [1] |
 | (10)-Gingerol | IC50 | 7500.0 [1], 16300.0 [2] |
 | 6-Chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline | IC50 | 100000.0 [1] |
 | Shogaol | IC50 | 3300.0 [1], 29200.0 [2] |
 | Pleconaril | IC50 | 10000.0 [1], 50118.72 [2] |
 | Desethylamodiaquine | IC50 | 58000.0 [1] |
 | I-Bet151 (gsk1210151A) | IC50 | 9900.0 [1] |
 | Quiflapon | IC50 | 0.5 [1], 500.0 [2] |
 | N-Hydroxy-N'-(4-butyl-2-methylphenyl)formamidine | IC50 | 3300.0 [1], 4170.0 [2] |
 | S1RA | IC50 | 10000.0 [1] |
 | Orteronel | IC50 | 30000.0 [1] |
 | Bms-536924 | IC50 | 1200.0 [1] |
 | Paradol | IC50 | 9900.0 [1], 13600.0 [2] |
 | N-[4-(4-Chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide | IC50 | 300.0 [1] |
 | Temsavir | IC50 | 25000.0 [1], 40000.0 [2] |
 | (8)-Gingerol | IC50 | 6800.0 [1], 8700.0 [2] |
 | 3-[[3-Fluoro-2-(methylsulfamoylamino)pyridin-4-yl]methyl]-4-methyl-7-pyrimidin-2-yloxychromen-2-one | IC50 | 12000.0 [1], 60000.0 [2] |
 | 4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine | IC50 | 10000.0 [1] |
 | (1S,3S,5S)-2-[(2S)-2-Amino-2-(3,5-dihydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | IC50 | 200000.0 [1] |
 | N-{4-[(3,5-Difluorophenyl)sulfonyl]benzyl}imidazo[1,2-A]pyridine-6-Carboxamide | IC50 | 200.0 [1], 10000.0 [2] |
 | Isoquine | IC50 | 75000.0 [1] |
 | 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide | IC50 | 100000.0 [1] |
 | SB 221284 | IC50 | 100000.0 [1] |
 | 2,3-Dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo[1,2-a]pyridine-6-carboxamide | IC50 | 3600.0 [1] |
 | 6-[2-[5-Chloro-2-[(2,4-difluorophenyl)methoxy]phenyl]-1-cyclopentenyl]pyridine-2-carboxylic Acid | IC50 | 14000.0 [1], 25000.0 [2] |
 | 1-(2-Cyclopropylethyl)-3-(1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxyquinolin-2-one | IC50 | 840.0 [1], 1000.0 [2] |
 | 4-(5-Chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)quinolin-2(1H)-one | IC50 | 1700.0 [1] |
 | CID 11691484 | IC50 | 5800.0 [1], 8000.0 [2] |
 | Unii-K4kac9xcco | IC50 | 40000.0 [1], 41000.0 [2] |
 | N-(4-{[3-(Trifluoromethyl)phenyl]sulfonyl}benzyl)-2h-Pyrazolo[3,4-B]pyridine-5-Carboxamide | IC50 | 70.0 [1], 4800.0 [2] |
 | 4-Methoxy-3-(1-methylpiperidin-4-yl)oxy-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]benzamide | IC50 | 30000.0 [1] |
 | N-(4-(Trifluoromethyl)oxazol-2-yl)-9H-xanthene-9-carboxamide | IC50 | 600.0 [1] |
 | N~3~-Cyclopropyl-N~4~'-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4'-Dicarboxamide | IC50 | 3981.07 [1], 4400.0 [2] |
 | 4-[3-[6-[3-(1,3-Benzodioxol-5-yl)-5-thiophen-3-ylphenoxy]hexyl]-2-(2-carboxyethyl)phenoxy]butanoic acid | IC50 | 3900.0 [1], 22500.0 [2] |
 | (3R)-N-Isoquinolin-3-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine | IC50 | 40000.0 [1] |
 | CID 46244454 | IC50 | 10000.0 [1] |
 | 1-Cyclohexyl-2-(furan-3-yl)-N-[(1S)-2-(5-hydroxy-1H-indol-3-yl)-1-(1,3-thiazol-4-yl)ethyl]benzimidazole-5-carboxamide | IC50 | 2300.0 [1] |
 | 3-(1-Naphthyl)-1-(4-pyridinyl)-2-propen-1-one | IC50 | 10000.0 [1], 20000.0 [2] |
 | 5-(4-Chlorophenyl)-N-(4-piperazin-1-ylphenyl)-N-(pyridin-2-ylmethyl)furan-2-carboxamide | IC50 | 20000.0 [1] |
 | (E)-3-(2-Chlorophenyl)-1-(1H-pyrrol-2-yl)prop-2-en-1-one | IC50 | 10000.0 [1], 20000.0 [2] |
 | 3-[4-(Trifluoromethyl)-6-[2-(trifluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene | IC50 | 10000.0 [1] |
 | 1-Cyano-3-(2-methyl-1-benzofuran-5-yl)-2-[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]guanidine | IC50 | 29200.0 [1], 200000.0 [2] |
 | 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]acetamide | IC50 | 100000.0 [1] |
 | Bms-344577 | IC50 | 40000.0 [1], 200000.0 [2] |
 | 2-(4-Fluorophenyl)-N-[6-methoxy-5-(4-methylimidazol-1-yl)pyridin-2-yl]-1-methylbenzimidazol-4-amine | IC50 | 21900.0 [1] |
 | 5-[(3R)-3-Hydroxypyrrolidine-1-carbonyl]-3-methyl-1-(2-methylpropyl)-6-(quinolin-4-ylmethyl)thieno[2,3-d]pyrimidine-2,4-dione | IC50 | 16000.0 [1] |
 | CID 58282870 | IC50 | 5000.0 [1] |
 | N-[4-[(1R,2R)-2-(Dimethylamino)-1-imidazol-1-ylpropyl]phenyl]-1,3-benzothiazol-2-amine | IC50 | 5900.0 [1], 11000.0 [2] |
 | Linaprazan | IC50 | 14000.0 [1], 31000.0 [2] |
 | (5-Pyrid-3-ylthien-2-YL)methylamine | IC50 | 8900.0 [1] |
| (5-Pyrid-3-ylthien-2-YL)methylamine | Ki | 4500.0 [1] |
 | (5-(Pyridin-3-YL)furan-2-YL)methanamine | IC50 | 11700.0 [1] |
| (5-(Pyridin-3-YL)furan-2-YL)methanamine | Ki | 5900.0 [1] |
 | 2-{3-[4-(2-Chloro-4-hydroxyphenyl)phenyl]propanamido}benzoic acid | IC50 | 400.0 [1] |
 | Nav1.7-IN-3 | IC50 | 20000.0 [1], 50000.0 [2] |
 | 4-[[2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 18.0 [1], 40.0 [2] |
 | 3-[(E)-[3-[(E)-2-[4-[(Dimethylamino)methyl]phenyl]ethenyl]indazol-6-ylidene]methyl]-1H-indol-2-ol | IC50 | 1300.0 [1], 1400.0 [2] |
 | [3-[4-[[(3S,5R)-3,5-Dimethylpiperazin-1-yl]methyl]phenyl]pyridin-2-yl]-[4-(4-fluoroanilino)piperidin-1-yl]methanone | IC50 | 23000.0 [1], 100000.0 [2] |
Calculator
